229 related articles for article (PubMed ID: 35107704)
1. Strategies for Imaging Metabolic Remodeling of the Heart in Obesity and Heart Failure.
Haidar A; Taegtmeyer H
Curr Cardiol Rep; 2022 Apr; 24(4):327-335. PubMed ID: 35107704
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
4. Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.
Valkema R; van Eck-Smit BL; van der Wall EE
J Nucl Cardiol; 1994; 1(6):546-60. PubMed ID: 9420749
[TBL] [Abstract][Full Text] [Related]
5. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
6. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
[TBL] [Abstract][Full Text] [Related]
7. Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
Abdurrachim D; Nabben M; Hoerr V; Kuhlmann MT; Bovenkamp P; Ciapaite J; Geraets IME; Coumans W; Luiken JJFP; Glatz JFC; Schäfers M; Nicolay K; Faber C; Hermann S; Prompers JJ
Cardiovasc Res; 2017 Aug; 113(10):1148-1160. PubMed ID: 28549111
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid imaging of the heart.
Giedd KN; Bergmann SR
Curr Cardiol Rep; 2011 Apr; 13(2):121-31. PubMed ID: 21240641
[TBL] [Abstract][Full Text] [Related]
9. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.
van der Meer RW; Rijzewijk LJ; de Jong HW; Lamb HJ; Lubberink M; Romijn JA; Bax JJ; de Roos A; Kamp O; Paulus WJ; Heine RJ; Lammertsma AA; Smit JW; Diamant M
Circulation; 2009 Apr; 119(15):2069-77. PubMed ID: 19349323
[TBL] [Abstract][Full Text] [Related]
11. Imaging myocardial metabolic remodeling.
Gropler RJ; Beanlands RS; Dilsizian V; Lewandowski ED; Villanueva FS; Ziadi MC
J Nucl Med; 2010 May; 51 Suppl 1(Suppl 1):88S-101S. PubMed ID: 20457796
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive evaluation of fat-carbohydrate metabolic switching in heart and contracting skeletal muscle.
DeGrado TR; Pandey MK; Belanger AP; Basuli F; Bansal A; Wang S
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E251-E259. PubMed ID: 30512988
[TBL] [Abstract][Full Text] [Related]
13. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Obesity and Hypertension on Cardiac Metabolic Remodeling and Survival Following Myocardial Infarction.
Mouton AJ; Flynn ER; Moak SP; Li X; da Silva AA; Wang Z; do Carmo JM; Hall ME; Hall JE
J Am Heart Assoc; 2021 Mar; 10(6):e018212. PubMed ID: 33666098
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics.
Warren JS; Oka SI; Zablocki D; Sadoshima J
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H584-H596. PubMed ID: 28646024
[TBL] [Abstract][Full Text] [Related]
16. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
[TBL] [Abstract][Full Text] [Related]
17. Early Imaging Biomarker of Myocardial Glucose Adaptations in High-Fat-Diet-Induced Insulin Resistance Model by Using
Chung YH; Lu KY; Chiu SC; Lo CJ; Hung LM; Huang JP; Cheng ML; Wang CH; Tsai CK; Lin YC; Chang SH; Lin G
Contrast Media Mol Imaging; 2018; 2018():8751267. PubMed ID: 30116165
[TBL] [Abstract][Full Text] [Related]
18. Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.
Lucas E; Vila-Bedmar R; Arcones AC; Cruces-Sande M; Cachofeiro V; Mayor F; Murga C
Cardiovasc Diabetol; 2016 Nov; 15(1):155. PubMed ID: 27832814
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Changes Precede Radiation-Induced Cardiac Remodeling in Beagles: Using Noninvasive
Yan R; Li X; Song J; Guo M; Cai H; Wu Z; Wu P; Li L; Yang M; Wang Y; Li S
J Am Heart Assoc; 2020 Sep; 9(18):e016875. PubMed ID: 32914660
[TBL] [Abstract][Full Text] [Related]
20. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
Schram K; Sweeney G
Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
